News | June 24, 2024
EMA approves Biocon Biologics’ new mAbs facility in India
Renews GMP certifications for India and Malaysia sites
Renews GMP certifications for India and Malaysia sites
Second FDA approval for KRAZATI - reinforcing its potential across tumor types
Augtyro is the only FDA-approved treatment option for NTRK-positive tumors studied in both TKI-naïve and TKI-pretreated patients across solid tumors
Higher efficacy was observed in mRNA-1283 compared to Spikevax in adults 18 years of age and older
The primary endpoint in the final analysis was assessed by change in the North Star Ambulatory Assessment at one year after treatment
Private financing round supported by Fidelity Management & Research Company, T. Rowe Price and Durable Capital Partners
Accelerating sustainability in Indian pharma industry
Abbott's first-of-its-kind i2i technology enables synchronized communication between two leadless pacemakers
Ashkenazi will continue to serve at full capacity in her role and as a member of Lilly's Executive Committee through July 2024
Merck has opened its newly expanded Life Science distribution center in Schnelldorf, Germany
Subscribe To Our Newsletter & Stay Updated
